NCT00301834 2017-09-28Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic DisordersUniversity of California, San FranciscoPhase 2 Completed35 enrolled 11 charts
NCT00281879 2017-09-27Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic CancerOHSU Knight Cancer InstitutePhase 2 Terminated200 enrolled 11 charts